Todd Franklin Watanabe, President and CEO at Arcutis Biotherapeutics, Inc. (ARQT), sold 25,500 shares at $25.41 ($647K) on 2022-07-08, disclosed to the SEC on 2022-07-12.
Open-market sale of $647k ARQT by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 1,500 | $38K | 5.8% |
| 2 | $25.41 | 4,913 | $125K | 19.3% |
| 3 | $25.41 | 4,913 | $125K | 19.3% |
| 4 | $25.41 | 7,087 | $180K | 27.8% |
| 5 | $25.41 | 7,087 | $180K | 27.8% |
| Total | $25.39 avg | 25,500 |
| $647K |
| 100% |
| Filing → |
| ARQT | SELL | 2025-03-20 | $21K | — | Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $490K | — | Filing → |